,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
239,.,.,HGMD|OMIM|low_frequency,"Name=GCcontent,LowComplexity",.,WAX051,613388;616963;612286,"Fanconi renotubular syndrome 2;Hypercalcemia, infantile, 2;Nephrolithiasis/osteoporosis, hypophosphatemic, 1","1.$$$mimNumber,613388###prefix,####preferredTitle,FANCONI RENOTUBULAR SYNDROME 2; FRTS2###inheritance,Autosomal recessive ###growthHeight,Short stature ###genitourinaryKidneys,Proximal tubulopathy, generalized ;###genitourinaryKidneys,Decreased renal tubular reabsorption of phosphate ;###genitourinaryKidneys,Renal failure, mild to moderate ###skeletal,Osteopenia ;###skeletal,Rickets, severe ###muscleSoftTissue,Muscle weakness ###laboratoryAbnormalities,Hypophosphatemia ;###laboratoryAbnormalities,Increased serum alkaline phosphatase activity of skeletal origin ;###laboratoryAbnormalities,1,25-dihydroxyvitamin D was elevated in childhood but deficient in adulthood ;###laboratoryAbnormalities,Hypercalciuria (in childhood) ;###laboratoryAbnormalities,Glucosuria ;###laboratoryAbnormalities,Aminoaciduria, generalized ;###laboratoryAbnormalities,Urinary excretion of low-molecular-weight proteins, mild ;###laboratoryAbnormalities,Increased fractional excretion of uric acid ###molecularBasis,Caused by mutation in the solute carrier family 34 (sodium phosphate cotransporter), member 1 gene (SLC34A1, ) 2.$$$mimNumber,616963###prefix,####preferredTitle,HYPERCALCEMIA, INFANTILE, 2; HCINF2###inheritance,Autosomal recessive ###growthOther,Failure to thrive ###genitourinaryKidneys,Polyuria ;###genitourinaryKidneys,Hypercalciuria ;###genitourinaryKidneys,Nephrocalcinosis ;###genitourinaryKidneys,Reduced tubular phosphate resorption###muscleSoftTissue,Muscular hypotonia (in some patients) ###metabolicFeatures,Hypercalcemia ;###metabolicFeatures,Hypophosphatemia ;###metabolicFeatures,Elevated calcitriol (active 1,25-(OH)2D3) levels (in some patients)###endocrineFeatures,Low parathyroid hormone (PTH) levels###miscellaneous,All patients received vitamin D prophylaxis in infancy###molecularBasis,Caused by mutation in the solute carrier family 34 (type II sodium/phosphate cotransporter) member-1 gene (SLC34A1, ) 3.$$$mimNumber,612286###prefix,####preferredTitle,NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1; NPHLOP1###inheritance,Autosomal dominant ###genitourinaryKidneys,Nephrolithiasis ;###genitourinaryKidneys,Renal phosphate wasting ###skeletal,Osteopenia ;###skeletal,Osteoporosis ;###skeletal,Increased susceptibility to fractures ###skeletalSpine,Spinal deformity ###laboratoryAbnormalities,Hypophosphatemia ;###laboratoryAbnormalities,Hyperphosphaturia ;###laboratoryAbnormalities,Hypercalciuria ;###laboratoryAbnormalities,Increased serum 1,25-dihydroxyvitamin D ###molecularBasis,Caused by mutation in the solute carrier family 34 (sodium/phosphate cotransporter), member 1 gene (SLC34A1, )",https://www.omim.org/entry/613388;https://www.omim.org/entry/616963;https://www.omim.org/entry/612286,.,Autosomal recessive;Autosomal dominant,Het,5,176824007,G,A,.,.,strand fail|low coverage,0/1:5:10,50.0,",$a,,aa,,AA",missense_variant,SLC34A1,6569,.,NM_003052.4(SLC34A1):c.1348G>A(p.Gly450Ser),NM_003052.4,exon12(13),P0=>P0,0.004,0.0008,0,0,0.0003,0.0034,0.0003,0.0037,0,31,0.0036,0,36,0.00030,0.00819672131148,4/488,http://exac.broadinstitute.org/variant/5-176824007-G-A,-1.09,17.5,21,0.0,http://exac.broadinstitute.org/gene/ENSG00000131183,0.96704,.,0,D,1.0,D,0.999,D,0.000,D,1.000,D,5.39,36,rs34044544,.,.,.,.,NM_003052.4(SLC34A1):c.1348G>A(p.G450S),DM,Hypophosphataemic nephrolithiasis/osteoporosis 1/Fanconi syndrome,26787776,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,arsenate ion transmembrane transport (GO:1901684)|bone remodeling (GO:0046849)|cellular response to metal ion (GO:0071248)|cellular response to parathyroid hormone stimulus (GO:0071374)|cellular response to staurosporine (GO:0072734)|dentinogenesis (GO:0097187)|gentamycin metabolic process (GO:1901128)|glycoprotein metabolic process (GO:0009100)|indole metabolic process (GO:0042431)|ion transport (GO:0006811)|kidney development (GO:0001822)|ossification (GO:0001503)|phosphate ion homeostasis (GO:0055062)|phosphate ion transport (GO:0006817)|positive regulation of membrane potential (GO:0045838)|positive regulation of phosphate transmembrane transport (GO:2000187)|positive regulation of sodium-dependent phosphate transport (GO:2000120)|protein homooligomerization (GO:0051260)|response to cadmium ion (GO:0046686)|response to drug (GO:0042493)|response to estradiol (GO:0032355)|response to growth hormone (GO:0060416)|response to lead ion (GO:0010288)|response to magnesium ion (GO:0032026)|response to mercury ion (GO:0046689)|response to potassium ion (GO:0035864)|response to thyroid hormone (GO:0097066)|response to vitamin A (GO:0033189)|sodium ion transport (GO:0006814)|transmembrane transport (GO:0055085)|tricarboxylic acid metabolic process (GO:0072350),apical plasma membrane (GO:0016324)|basolateral plasma membrane (GO:0016323)|brush border membrane (GO:0031526)|cell surface (GO:0009986)|endosome (GO:0005768)|integral component of plasma membrane (GO:0005887)|membrane raft (GO:0045121)|membrane-bounded vesicle (GO:0031988)|perinuclear region of cytoplasm (GO:0048471)|plasma membrane (GO:0005886),sodium-dependent phosphate transmembrane transporter activity (GO:0015321)|symporter activity (GO:0015293),.,.,.,.,48,2,AX051
282,.,.,HGMD|OMIM|low_frequency,"Name=GCcontent,LowComplexity,SegmentalDuplications",.,WAX051,123100;180750;101400,Craniosynostosis 1;Robinow-Sorauf syndrome;Saethre-Chotzen syndrome;Saethre-Chotzen syndrome with eyelid anomalies,"1.$$$mimNumber,101400###prefix,####preferredTitle,SAETHRE-CHOTZEN SYNDROME; SCS###inheritance,Autosomal dominant ###growthHeight,Short stature ###headAndNeckHead,Brachycephaly ;###headAndNeckHead,Acrocephaly ###headAndNeckFace,Flat face ;###headAndNeckFace,High, flat forehead ;###headAndNeckFace,Low frontal hairline ;###headAndNeckFace,Maxillary hypoplasia ;###headAndNeckFace,Facial asymmetry ###headAndNeckEars,Long and prominent ear crus ;###headAndNeckEars,Small ears ;###headAndNeckEars,Low-set ears ;###headAndNeckEars,Apical cartilage deformity ;###headAndNeckEars,Deafness ###headAndNeckEyes,Shallow orbits ;###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Plagiocephaly (asymmetry of orbits) ;###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Buphthalmos ;###headAndNeckEyes,Ptosis ;###headAndNeckEyes,S-shaped blepharoptosis ;###headAndNeckEyes,Lacrimal duct abnormalities ###headAndNeckNose,Thin, long, pointed nose ;###headAndNeckNose,Beaked nose ###headAndNeckMouth,Narrow palate ;###headAndNeckMouth,Cleft palate ###cardiovascularHeart,Congenital heart defect ###cardiovascularVascular,Intracranial hypertension due to multisutural cranial fusion ###skeletalSkull,Late closing fontanelles ;###skeletalSkull,Craniosynostosis of coronal, lambdoid, and/or metopic sutures ;###skeletalSkull,Acrocephaly ;###skeletalSkull,Parietal foramina ###skeletalPelvis,Small ilia ;###skeletalPelvis,Large ischia ###skeletalLimbs,Radioulnar synostosis ###skeletalHands,Mild syndactyly (often 2nd-3rd fingers) ;###skeletalHands,Bifid terminal phalanges digits 2 and 3 ;###skeletalHands,Absent first metatarsal ;###skeletalHands,Brachydactyly ;###skeletalHands,Fifth finger clinodactyly ###skeletalFeet,Syndactyly (often 3rd-4th toes) ;###skeletalFeet,Hallux valgus ###neoplasia,Increased risk of breast cancer in women ###miscellaneous,Few patients with mild to moderate mental retardation ;###miscellaneous,Variable expressivity ;###miscellaneous,Incidence of 1 in 25,000 to 1 in 50,000 newborns ;###miscellaneous,Phenotypic overlap with Munke syndrome ()###molecularBasis,Caused by mutation in the TWIST transcription factor gene (TWIST, ) 2.$$$mimNumber,101400###prefix,####preferredTitle,SAETHRE-CHOTZEN SYNDROME; SCS###inheritance,Autosomal dominant ###growthHeight,Short stature ###headAndNeckHead,Brachycephaly ;###headAndNeckHead,Acrocephaly ###headAndNeckFace,Flat face ;###headAndNeckFace,High, flat forehead ;###headAndNeckFace,Low frontal hairline ;###headAndNeckFace,Maxillary hypoplasia ;###headAndNeckFace,Facial asymmetry ###headAndNeckEars,Long and prominent ear crus ;###headAndNeckEars,Small ears ;###headAndNeckEars,Low-set ears ;###headAndNeckEars,Apical cartilage deformity ;###headAndNeckEars,Deafness ###headAndNeckEyes,Shallow orbits ;###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Plagiocephaly (asymmetry of orbits) ;###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Buphthalmos ;###headAndNeckEyes,Ptosis ;###headAndNeckEyes,S-shaped blepharoptosis ;###headAndNeckEyes,Lacrimal duct abnormalities ###headAndNeckNose,Thin, long, pointed nose ;###headAndNeckNose,Beaked nose ###headAndNeckMouth,Narrow palate ;###headAndNeckMouth,Cleft palate ###cardiovascularHeart,Congenital heart defect ###cardiovascularVascular,Intracranial hypertension due to multisutural cranial fusion ###skeletalSkull,Late closing fontanelles ;###skeletalSkull,Craniosynostosis of coronal, lambdoid, and/or metopic sutures ;###skeletalSkull,Acrocephaly ;###skeletalSkull,Parietal foramina ###skeletalPelvis,Small ilia ;###skeletalPelvis,Large ischia ###skeletalLimbs,Radioulnar synostosis ###skeletalHands,Mild syndactyly (often 2nd-3rd fingers) ;###skeletalHands,Bifid terminal phalanges digits 2 and 3 ;###skeletalHands,Absent first metatarsal ;###skeletalHands,Brachydactyly ;###skeletalHands,Fifth finger clinodactyly ###skeletalFeet,Syndactyly (often 3rd-4th toes) ;###skeletalFeet,Hallux valgus ###neoplasia,Increased risk of breast cancer in women ###miscellaneous,Few patients with mild to moderate mental retardation ;###miscellaneous,Variable expressivity ;###miscellaneous,Incidence of 1 in 25,000 to 1 in 50,000 newborns ;###miscellaneous,Phenotypic overlap with Munke syndrome ()###molecularBasis,Caused by mutation in the TWIST transcription factor gene (TWIST, )",https://www.omim.org/entry/123100;https://www.omim.org/entry/180750;https://www.omim.org/entry/101400,.,Autosomal dominant,Het,7,19156669,GCCGCCGCCGCCGCCCGC,-,.,Name=321:(CCG)n:Simple_repeat,strand fail|low coverage,0/1:3:6,50.0,".,,,-18gccgccgccgccgcccgc.-18GCCGCCGCCGCCGCCCGC.",inframe_deletion,TWIST1,7291,.,NM_000474.3(TWIST1):c.259_276delGCGGGCGGCGGCGGCGGC(p.Ala87_Gly92del),NM_000474.3,exon1(2),.,0.002,0.0014,.,.,0.0090,0.1049,0.0034,0.0224,0,6,0.0065,0,27,0.0014,.,.,http://exac.broadinstitute.org/variant/7-19156668-TGCCGCCGCCGCCGCCCGC-T,3.82,2.3,1,0.18,http://exac.broadinstitute.org/gene/ENSG00000122691,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"NM_000474.3(TWIST1):c.260_274dupCGGGCGGCGGCGGCG,DM,Craniosynostosis,11748846;NM_000474.3(TWIST1):c.259_276delGCGGGCGGCGGCGGCGGC,NM_000474.3(TWIST1):c.276_277insGGCGGCCGGC,DM?,DM,Synostotic frontal plagiocephaly,Saethre-Chotzen syndrome,15253176,10649491",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"aortic valve morphogenesis (GO:0003180)|cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253)|cell proliferation involved in heart valve development (GO:2000793)|cellular response to growth factor stimulus (GO:0071363)|cellular response to hypoxia (GO:0071456)|cranial suture morphogenesis (GO:0060363)|embryonic camera-type eye formation (GO:0060900)|embryonic cranial skeleton morphogenesis (GO:0048701)|embryonic digit morphogenesis (GO:0042733)|embryonic forelimb morphogenesis (GO:0035115)|embryonic hindlimb morphogenesis (GO:0035116)|endocardial cushion morphogenesis (GO:0003203)|eyelid development in camera-type eye (GO:0061029)|in utero embryonic development (GO:0001701)|mitral valve morphogenesis (GO:0003183)|muscle organ development (GO:0007517)|negative regulation of apoptotic process (GO:0043066)|negative regulation of cellular senescence (GO:2000773)|negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)|negative regulation of double-strand break repair (GO:2000780)|negative regulation of histone acetylation (GO:0035067)|negative regulation of histone phosphorylation (GO:0033128)|negative regulation of osteoblast differentiation (GO:0045668)|negative regulation of oxidative phosphorylation uncoupler activity (GO:2000276)|negative regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035359)|negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067)|negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)|negative regulation of skeletal muscle tissue development (GO:0048642)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|negative regulation of tumor necrosis factor production (GO:0032720)|neural tube closure (GO:0001843)|neuron migration (GO:0001764)|odontogenesis (GO:0042476)|ossification (GO:0001503)|osteoblast differentiation (GO:0001649)|outer ear morphogenesis (GO:0042473)|palate development (GO:0060021)|positive regulation of angiogenesis (GO:0045766)|positive regulation of cell motility (GO:2000147)|positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000802)|positive regulation of epithelial cell proliferation (GO:0050679)|positive regulation of epithelial to mesenchymal transition (GO:0010718)|positive regulation of fatty acid beta-oxidation (GO:0032000)|positive regulation of gene expression (GO:0010628)|positive regulation of interleukin-6 secretion (GO:2000778)|positive regulation of monocyte chemotactic protein-1 production (GO:0071639)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription regulatory region DNA binding (GO:2000679)|positive regulation of tumor necrosis factor production (GO:0032760)|regulation of bone mineralization (GO:0030500)|rhythmic process (GO:0048511)|transcription from RNA polymerase II promoter (GO:0006366)",nucleus (GO:0005634),bHLH transcription factor binding (GO:0043425)|E-box binding (GO:0070888)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|transcription factor binding (GO:0008134),.,.,.,.,39,1,AX051
394,.,.,OMIM|low_frequency,.,.,WAX051,607785;613563,?Juvenile myelomonocytic leukemia;Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia,"1.$$$mimNumber,607785###prefix,####preferredTitle,JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML###inheritance,Autosomal dominant ;###inheritance,Somatic mutation ###hematology,Juvenile myelomonocytic leukemia ###miscellaneous,One family has been reported with germline CBL mutation (last curated May 2016)###molecularBasis,Caused by mutation in the CBL gene (CBL, );###molecularBasis,Caused by mutation in the NF1 gene (NF1, );###molecularBasis,Caused by somatic mutation in the RHO GTPase-activating protein 26 gene (ARHGAP26, 605370.0001});###molecularBasis,Caused by somatic mutation in the protein tyrosine phosphatase, nonreceptor-type, 11 gene (PTPN11, 176876.0014});###molecularBasis,Caused by somatic mutation in the neuroblastoma Ras viral oncogene (NRAS, 164790.0003});###molecularBasis,Caused by somatic mutation in the Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog gene (KRAS, ) 2.$$$mimNumber,613563###prefix,####preferredTitle,NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL###inheritance,Autosomal dominant ###growthHeight,Short stature (in some patients) ###headAndNeckFace,Frontal bossing ;###headAndNeckFace,Triangular face ;###headAndNeckFace,Long philtrum ###headAndNeckEars,Large ears ;###headAndNeckEars,Low-set ears ###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Ptosis ;###headAndNeckEyes,Downslanting palpebral fissures ###headAndNeckNose,Depressed nasal bridge ###headAndNeckMouth,Thick lips ###headAndNeckNeck,Short neck ;###headAndNeckNeck,Webbed neck ###cardiovascularHeart,Congenital heart defects ;###cardiovascularHeart,Aortic stenosis ;###cardiovascularHeart,Mitral insufficiency ###respiratoryLung,Pleural effusions due to chylothorax (in some patients) ###chestExternalFeatures,Pectus excavatum ###chestBreasts,Widely spaced nipples ###genitourinaryInternalGenitaliaMale,Cryptorchidism ###skeletal,Joint laxity ###skeletalLimbs,Cubitus valgus ###skinNailsHairSkin,Cafe-au-lait spots ;###skinNailsHairSkin,Lymphedema (in some patients) ###skinNailsHairHair,Thin hair ###muscleSoftTissue,Hypotonia ###neurologicCentralNervousSystem,Delayed psychomotor development, mild ;###neurologicCentralNervousSystem,Language delay ###neoplasia,Increased susceptibility to juvenile myelomonocytic leukemia ###prenatalManifestationsAmnioticFluid,Polyhydramnios (in some patients ;###prenatalManifestationsAmnioticFluid,Fetal hydrops (in some patients) ###miscellaneous,Variable phenotype ###molecularBasis,Caused by mutation in the Cas-Br-M murine ecotropic retroviral transforming sequence homolog gene (CBL, )",https://www.omim.org/entry/607785;https://www.omim.org/entry/613563,.,"Autosomal dominant, Somatic mutation;Autosomal dominant",Het,11,119170339,C,T,.,.,PASS,0/1:34:71,47.89,"tTt.T.,,t,t,..tT.TT,,t,,t.,.,TTTTt,t,t,T..,t,T....T.,tt..tt.ttTt,tT",missense_variant,CBL,867,.,NM_005188.3(CBL):c.2569C>T(p.Leu857Phe),NM_005188.3,exon16(16),NP=>NP,0.001,0.0002,0,0,0.0002,0.0023,0.0003,0.0049,0,25,0.0029,0,25,0.00021,.,.,http://exac.broadinstitute.org/variant/11-119170339-C-T,1.73,36.4,11,0.01,http://exac.broadinstitute.org/gene/ENSG00000110395,0.44660,.,0,D,0.993,D,0.919,D,0.000,D,1.000,D,4.49,14.36,rs201631570,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"cell surface receptor signaling pathway (GO:0007166)|epidermal growth factor receptor signaling pathway (GO:0007173)|fibroblast growth factor receptor signaling pathway (GO:0008543)|negative regulation of apoptotic process (GO:0043066)|negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)|positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)|positive regulation of receptor-mediated endocytosis (GO:0048260)|protein ubiquitination (GO:0016567)|regulation of transcription, DNA-templated (GO:0006355)|transforming growth factor beta receptor signaling pathway (GO:0007179)",cytoplasm (GO:0005737)|cytosol (GO:0005829)|flotillin complex (GO:0016600)|nucleus (GO:0005634)|plasma membrane (GO:0005886),calcium ion binding (GO:0005509)|ephrin receptor binding (GO:0046875)|ligase activity (GO:0016874)|sequence-specific DNA binding transcription factor activity (GO:0003700)|SH3 domain binding (GO:0017124)|signal transducer activity (GO:0004871)|ubiquitin-protein transferase activity (GO:0004842)|zinc ion binding (GO:0008270),.,.,.,.,9,0,AX051
503,.,.,OMIM|low_frequency,.,.,WAX051,259600,"Multicentric osteolysis, nodulosis, and arthropathy","1.$$$mimNumber,259600###prefix,####preferredTitle,MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA###inheritance,Autosomal recessive ###skeletal,Osteoporosis ###skeletalPelvis,Flexion contracture (hip) ###skeletalLimbs,Flexion contractures (elbows and knees) ###skeletalHands,Fusiform finger swelling ;###skeletalHands,Interphalangeal joint erosions ;###skeletalHands,Finger contractures ;###skeletalHands,Carpal osteolysis ;###skeletalHands,Widened metacarpal shaft ;###skeletalHands,Thin metacarpal cortices ###skeletalFeet,Pes planus ;###skeletalFeet,Pes cavus ;###skeletalFeet,Tarsal osteolysis ;###skeletalFeet,Widened metatarsal shaft ;###skeletalFeet,Interphalangeal joint erosions ;###skeletalFeet,Thin metatarsal cortices ###skinNailsHairSkin,Subcutaneous nodules (interphalangeal joints, knees, feet, elbows, pretibial) ;###skinNailsHairSkin,Hyperpigmented erythematous lesions ###laboratoryAbnormalities,Elevated antinuclear antibody (ANA) (speckled pattern) ;###laboratoryAbnormalities,Elevated IL1-beta ;###laboratoryAbnormalities,Elevated IL6 ###miscellaneous,Abnormal gait ###molecularBasis,Caused by mutation in the matrix metalloproteinase 2 gene (MMP2, )",https://www.omim.org/entry/259600,.,Autosomal recessive,Het,16,55530864,G,A,.,.,PASS,0/1:23:40,57.5,"A.AAAaA..aa.,aAA,A.AA,a,,A.a.,..aaA",missense_variant;missense_variant,MMP2,4313,.,NM_004530.4(MMP2):c.1499G>A(p.Arg500His);NM_001127891.1(MMP2):c.1349G>A(p.Arg450His),NM_004530.5,exon10(13);exon10(13),P+=>P+;P+=>P+,0.0089,0.0034,37,0.0028,0.0012,0.0091,0.0023,0.0086,0,74,0.0086,1,171,0.0014,0.00819672131148,4/488,http://exac.broadinstitute.org/variant/16-55530864-G-A,1.22,22.5,4,0.79,http://exac.broadinstitute.org/gene/ENSG00000087245,0.71373,1.16E-4,0.09,T,0.958,D,0.456,P,0.005,N,1.000,N,2.0,19.49,rs28730814,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,angiogenesis (GO:0001525)|blood vessel maturation (GO:0001955)|bone trabecula formation (GO:0060346)|cellular protein metabolic process (GO:0044267)|cellular response to amino acid stimulus (GO:0071230)|collagen catabolic process (GO:0030574)|embryo implantation (GO:0007566)|endodermal cell differentiation (GO:0035987)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|face morphogenesis (GO:0060325)|intramembranous ossification (GO:0001957)|positive regulation of innate immune response (GO:0045089)|proteolysis (GO:0006508)|response to hypoxia (GO:0001666),extracellular region (GO:0005576)|extracellular space (GO:0005615)|mitochondrion (GO:0005739)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|proteinaceous extracellular matrix (GO:0005578)|sarcomere (GO:0030017),metalloendopeptidase activity (GO:0004222)|serine-type endopeptidase activity (GO:0004252)|zinc ion binding (GO:0008270),.,.,.,.,54,4,AX051
607,.,.,HGMD|OMIM,Name=SegmentalDuplications,.,WAX051,244200,Hypogonadotropic hypogonadism 3 with or without anosmia,"1.$$$mimNumber,244200###prefix,####preferredTitle,HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3###inheritance,Autosomal dominant ###headAndNeckEars,Hearing loss (rare) ###headAndNeckNose,Hyposmia/anosmia (in some patients) ###chestExternalFeatures,Pectus excavatum ###chestBreasts,Delayed or absent thelarche ###genitourinaryExternalGenitaliaMale,Micropenis ;###genitourinaryExternalGenitaliaMale,Cryptorchidism ###genitourinaryInternalGenitaliaFemale,Primary amenorrhea ###skeletalHands,Hyperlaxity of digits (rare) ###skeletalFeet,Pes planus ###muscleSoftTissue,Fibrous dysplasia (rare) ###neurologicCentralNervousSystem,Synkinesia ;###neurologicCentralNervousSystem,Seizures (rare) ###endocrineFeatures,Hypogonadotropic hypogonadism ;###endocrineFeatures,Delayed or absent puberty ;###endocrineFeatures,Low to undetectable gonadotropin levels ;###endocrineFeatures,Low testosterone level ;###endocrineFeatures,Low estradiol level ###miscellaneous,Incomplete penetrance ;###miscellaneous,Some patients experience later reversal of hypogonadotropic hypogonadism ;###miscellaneous,Phenotype may be oligogenic in some patients who carry mutations in more than one HH-associated gene ###molecularBasis,Caused by mutation in the prokineticin receptor-2 gene (PROKR2, )",https://www.omim.org/entry/244200,.,Autosomal dominant,Het,20,5282731,G,A,.,.,PASS,0/1:55:100,55.0,"a..aA,aA,A.,A.a.AaA.,a,A,,,,Aa,AA..aa,AAAAaAaA.aA.AA.aA.A.AAA.aa.A.AAa..,.A.AAaa..A.A.A,,,A.",synonymous_variant,PROKR2,128674,.,NM_144773.2(PROKR2):c.1110C>T(p.Asn370=),NM_144773.2,exon2(2),.,0.029,0.012,1,0.000077,0.0062,0.0315,0.0020,0.0358,3,250,0.029,15,792,0.0065,0.0614754098361,30/488,http://exac.broadinstitute.org/variant/20-5282731-G-A,0.23,5.6,5,0.0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,rs76049287,.,.,.,.,.,.,.,.,.,.,.,.,"NM_144773.2(PROKR2):c.1111G>C(p.G371R),DM?,Hypopituitarism and septo-optic dysplasia,23312594",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,circadian rhythm (GO:0007623),integral component of membrane (GO:0016021)|plasma membrane (GO:0005886),neuropeptide Y receptor activity (GO:0004983),.,.,.,.,50,3,AX051
608,.,.,HGMD|OMIM,Name=SegmentalDuplications,.,WAX051,244200,Hypogonadotropic hypogonadism 3 with or without anosmia,"1.$$$mimNumber,244200###prefix,####preferredTitle,HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3###inheritance,Autosomal dominant ###headAndNeckEars,Hearing loss (rare) ###headAndNeckNose,Hyposmia/anosmia (in some patients) ###chestExternalFeatures,Pectus excavatum ###chestBreasts,Delayed or absent thelarche ###genitourinaryExternalGenitaliaMale,Micropenis ;###genitourinaryExternalGenitaliaMale,Cryptorchidism ###genitourinaryInternalGenitaliaFemale,Primary amenorrhea ###skeletalHands,Hyperlaxity of digits (rare) ###skeletalFeet,Pes planus ###muscleSoftTissue,Fibrous dysplasia (rare) ###neurologicCentralNervousSystem,Synkinesia ;###neurologicCentralNervousSystem,Seizures (rare) ###endocrineFeatures,Hypogonadotropic hypogonadism ;###endocrineFeatures,Delayed or absent puberty ;###endocrineFeatures,Low to undetectable gonadotropin levels ;###endocrineFeatures,Low testosterone level ;###endocrineFeatures,Low estradiol level ###miscellaneous,Incomplete penetrance ;###miscellaneous,Some patients experience later reversal of hypogonadotropic hypogonadism ;###miscellaneous,Phenotype may be oligogenic in some patients who carry mutations in more than one HH-associated gene ###molecularBasis,Caused by mutation in the prokineticin receptor-2 gene (PROKR2, )",https://www.omim.org/entry/244200,.,Autosomal dominant,Het,20,5282850,C,T,.,.,PASS,0/1:74:135,54.81,".$,$t$.,.T.TTttt..T..T,,T.TTTt..Ttt..t,T..T.t.,T,TtTTt...tt,,,,TT.tTTttT.T,TT,T....t,,tt.T,,T..TTttt.TttT.T,TtT,TT,TttTT,..,Tt..t",missense_variant,PROKR2,128674,.,NM_144773.2(PROKR2):c.991G>A(p.Val331Met),NM_144773.2,exon2(2),NP=>NP,0.028,0.012,.,.,0.0062,0.0317,0.0020,0.0358,3,251,0.029,15,792,0.0065,0.0614754098361,30/488,http://exac.broadinstitute.org/variant/20-5282850-C-T,0.23,5.6,5,0.0,.,0.17322,2.33E-4,0.18,T,0.043,B,0.013,B,0.003,N,0.997,N,2.01,8.526,rs117106081,.,.,.,.,NM_144773.2(PROKR2):c.991G>A(p.V331M),DM,Kallmann syndrome,17054399,NM_144773.2(PROKR2):c.990delC,DM,Kallmann syndrome,20022991,.,.,.,COSM84707,1(pancreas),.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,circadian rhythm (GO:0007623),integral component of membrane (GO:0016021)|plasma membrane (GO:0005886),neuropeptide Y receptor activity (GO:0004983),.,.,.,.,50,3,AX051
